Optimer Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Optimer Pharmaceuticals Ownership

Who owns Optimer Pharmaceuticals?

Optimer Pharmaceuticals is owned by Cubist Pharmaceuticals. It was acquired on October 24, 2013.

Optimer Pharmaceuticals Business Overview

Where is Optimer Pharmaceuticals headquartered?

Optimer Pharmaceuticals is headquartered in Jersey City, New Jersey.

How many employees does Optimer Pharmaceuticals have?

Optimer Pharmaceuticals has 281 employees.

What sector is Optimer Pharmaceuticals in?

Optimer Pharmaceuticals is a life science company.

When was Optimer Pharmaceuticals founded?

Optimer Pharmaceuticals was founded in 1998.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 192 acquisitions of life science companies in 2013, including 26 acquisitions by private equity firms, and 166 by strategics.

Optimer Pharmaceuticals, Inc.

101 Hudson Street, Suite 3501,
Jersey City, New Jersey 07302
United States,
(201) 333-8819
www.optimerpharma.com

Optimer Pharmaceuticals, Inc., a biopharmaceutical company currently focused on commercializing our antibiotic product DIFICID® (fidaxomicin) tablets in the United States and Canada, and developing other fidaxomicin products in the United States and worldwide, both independently and in our conjunction with partners and licensees.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.